Protagonist Therapeutics Inc (PTGX)
Financial leverage ratio
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 629,276 | 357,951 | 330,016 | 320,466 | 239,858 | 247,928 | 282,174 | 310,512 | 348,296 | 347,695 | 373,175 | 404,232 | 298,072 | 324,468 | 217,320 | 224,980 | 134,901 | 154,917 | 154,627 | 148,105 |
Total stockholders’ equity | US$ in thousands | 560,444 | 336,677 | 302,149 | 294,068 | 216,167 | 215,608 | 243,616 | 267,978 | 301,778 | 300,021 | 329,660 | 357,447 | 259,334 | 279,606 | 169,590 | 167,485 | 62,666 | 79,964 | 95,358 | 84,316 |
Financial leverage ratio | 1.12 | 1.06 | 1.09 | 1.09 | 1.11 | 1.15 | 1.16 | 1.16 | 1.15 | 1.16 | 1.13 | 1.13 | 1.15 | 1.16 | 1.28 | 1.34 | 2.15 | 1.94 | 1.62 | 1.76 |
March 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $629,276K ÷ $560,444K
= 1.12
The financial leverage ratio of Protagonist Therapeutics Inc has shown fluctuations over the past few quarters. The ratio increased steadily from Jun 2020 to Mar 2021, reaching a peak of 2.15 in Mar 2020, indicating high financial leverage during that period. However, from Mar 2021 onwards, the ratio started to decrease steadily, with occasional fluctuations, reaching a low of 1.06 in Dec 2023. This decrease suggests a reduction in financial risk and reliance on debt financing. Overall, the trend indicates that the company has been managing its debt levels effectively and has gradually improved its financial leverage position.
Peer comparison
Mar 31, 2024